F2R and cancer: Additionally, public data from GSE172016 demonstrated significantly high F2R expression in paclitaxel-resistant OVCAR3 and TOV21G cells, further supporting the role of F2R in sensitizing cancer cells to chemotherapy treatments (Figure S3).